These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15255089)

  • 21. Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents.
    Whitley RJ; Monto AS
    J Infect Dis; 2006 Nov; 194 Suppl 2():S133-8. PubMed ID: 17163386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychiatric concerns related to influenza treatment.
    Vantine M; Falahee ML; Vallerand AH
    Nurse Pract; 2009 Feb; 34(2):40-4. PubMed ID: 19155886
    [No Abstract]   [Full Text] [Related]  

  • 23. Outcome of influenza infection managed with oseltamivir in lung transplant recipients.
    Ison MG; Sharma A; Shepard JA; Wain JC; Ginns LC
    J Heart Lung Transplant; 2008 Mar; 27(3):282-8. PubMed ID: 18342750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influenza: a new treatment, oseltamivir].
    Vervaeren J
    J Pharm Belg; 2002; 57(5):97-102. PubMed ID: 12476676
    [No Abstract]   [Full Text] [Related]  

  • 25. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
    Wutzler P; Kossow KD; Lode H; Ruf BR; Scholz H; Vogel GE;
    J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis.
    Hayden FG; Belshe R; Villanueva C; Lanno R; Hughes C; Small I; Dutkowski R; Ward P; Carr J
    J Infect Dis; 2004 Feb; 189(3):440-9. PubMed ID: 14745701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.
    Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Kashiwagi S
    J Infect; 2009 Sep; 59(3):207-12. PubMed ID: 19619898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Oseltamivir].
    Taéron C
    Rev Infirm; 2005 Oct; (114):33-4. PubMed ID: 16359045
    [No Abstract]   [Full Text] [Related]  

  • 30. Oseltamivir.
    Nurs Times; 2005 Dec 13-2006 Jan 2; 101(50):32. PubMed ID: 16379449
    [No Abstract]   [Full Text] [Related]  

  • 31. Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation.
    Khanna N; Steffen I; Studt JD; Schreiber A; Lehmann T; Weisser M; Flückiger U; Gratwohl A; Halter J; Hirsch HH
    Transpl Infect Dis; 2009 Apr; 11(2):100-5. PubMed ID: 19175540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010.
    Greene SK; Li L; Shay DK; Fry AM; Lee GM; Jacobsen SJ; Baxter R; Irving SA; Jackson ML; Naleway AL; Nordin JD; Narwaney KJ; Lieu TA
    Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):335-44. PubMed ID: 23129321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of the influenza virus load by real-time polymerase chain reaction in nasopharyngeal swabs of patients treated with oseltamivir.
    Boivin G; Coulombe Z; Wat C
    J Infect Dis; 2003 Aug; 188(4):578-80. PubMed ID: 12898446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oseltamivir and abnormal behaviors: true or not?
    Yorifuji T; Suzuki E; Tsuda T
    Epidemiology; 2009 Jul; 20(4):619-21. PubMed ID: 19367165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost effectiveness of oseltamivir treatment of influenza: a critique of published methods and outcomes.
    Postma MJ; Beardsworth P; Wilschut JC
    J Med Econ; 2008; 11(4):743-68. PubMed ID: 19450079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Practice guideline 'Influenza prevention in nursing homes and care homes', issued by the Dutch Society of Nursing Home Specialists; division of tasks between nursing home specialist, general practitioner and company doctor].
    Cools HJ; van Essen GA;
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):119-24; discussion 116-8. PubMed ID: 15693586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Oseltamivir resistant avian influenza unsettling. Private hoarding of influenza agents a potential threat against public health].
    Uhnoo I; Linde A
    Lakartidningen; 2006 Feb 1-7; 103(5):298-300. PubMed ID: 16512569
    [No Abstract]   [Full Text] [Related]  

  • 38. Oseltamivir: cutaneous and neurological adverse effects in children.
    Prescrire Int; 2006 Oct; 15(85):182-3. PubMed ID: 17128526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir.
    Kawai N; Ikematsu H; Iwaki N; Kawashima T; Maeda T; Mitsuoka S; Kondou K; Satoh I; Miyachi K; Yamaga S; Shigematsu T; Hirotsu N; Kashiwagi S
    J Infect; 2007 Sep; 55(3):267-72. PubMed ID: 17604839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety of oseltamivir in patients with influenza: analysis of healthcare claims data from six influenza seasons.
    Blumentals WA; Song X
    MedGenMed; 2007 Oct; 9(4):23. PubMed ID: 18311373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.